Loading...

Media is loading
 

Date of Award

Spring 2021

Degree Name

Master of Medical Science (Physician Assistant)

Department

Physician Assistant; College of Health Sciences

First Advisor

Jodi Freeman

Abstract

Hospitals have seen an increase in Neonatal Abstinence Syndrome (NAS) cases, especially since the opioid epidemic outbreak. NAS is defined as the sudden withdrawal from illicit substances, specifically opioids, that were abused by the mother during the pregnancy. While there are defined treatment guidelines for adults going through opioid withdrawal, there hasn’t been the same for neonates. Over the years, Finnegan scoring guidelines have been used to assess the severity of withdrawal symptoms and determined the appropriate dose of morphine to manage the symptoms. However, it is unknown the side effects of using more morphine on a neonate already exposed to opioids during development. More recently, clinicians have been pushing for the use of Eat Sleep Console (ESC). This is a simplified evaluation of NAS infants and focuses on different comfort measures before administering morphine. Therefore, this review paper explores whether the Eat Sleep Console scoring exposes infants to less morphine than Finnegan scoring while appropriately managing withdrawal symptoms.

Additional Files

References for Poster.docx (14 kB)
Reference List

Poster presentation .pptx (1001 kB)

Share

COinS
 

Eat Sleep Console Method vs Finnegan Scoring in the treatment of Neonatal Abstinence Syndrome

Hospitals have seen an increase in Neonatal Abstinence Syndrome (NAS) cases, especially since the opioid epidemic outbreak. NAS is defined as the sudden withdrawal from illicit substances, specifically opioids, that were abused by the mother during the pregnancy. While there are defined treatment guidelines for adults going through opioid withdrawal, there hasn’t been the same for neonates. Over the years, Finnegan scoring guidelines have been used to assess the severity of withdrawal symptoms and determined the appropriate dose of morphine to manage the symptoms. However, it is unknown the side effects of using more morphine on a neonate already exposed to opioids during development. More recently, clinicians have been pushing for the use of Eat Sleep Console (ESC). This is a simplified evaluation of NAS infants and focuses on different comfort measures before administering morphine. Therefore, this review paper explores whether the Eat Sleep Console scoring exposes infants to less morphine than Finnegan scoring while appropriately managing withdrawal symptoms.